Paediatric tuberculosis and DOTS strategy under RNTCP

Area of Science:

• Pediatrics
• Infectious Diseases
• Public Health

Background:

• Tuberculosis (TB) infection in children primarily stems from adult exposure, with developing countries facing a 2-5% annual infection risk.
• Children account for 8-20% of TB-related deaths, highlighting the severity of the disease in this demographic.
• Diagnosing childhood TB is complex, often relying heavily on laboratory findings.

Purpose of the Study:

• To outline diagnostic guidelines for suspected, probable, and confirmed childhood tuberculosis.
• To recommend treatment regimens for pediatric TB patients within the Revised National Tuberculosis Control Program (RNTCP).
• To address challenges including drug resistance and co-infection with HIV in childhood TB.

Main Methods:

• Review and synthesis of existing guidelines for TB diagnosis in children.
• Discussion of treatment protocols recommended by TB experts and pediatricians.
• Highlighting innovations such as patientwise drug boxes under RNTCP.

Main Results:

• BCG vaccination effectively reduces disseminated and severe forms of TB in children.
• RNTCP offers specific treatment regimens and patientwise boxes for various pediatric age groups and weights.
• Drug resistance and HIV co-infection are critical considerations in managing childhood TB.

Conclusions:

• Standardized guidelines and RNTCP regimens are crucial for effective childhood TB management.
• Innovations like patientwise boxes improve adherence and treatment delivery.
• Addressing drug resistance and HIV co-infection is essential for comprehensive pediatric TB control. Chemoprophylaxis is vital for asymptomatic children under six.